Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Turning and unilateral cueing in Parkinson's disease patients with and without freezing of gait.
Spildooren J, Vercruysse S, Meyns P, Vandenbossche J, Heremans E, Desloovere K, Vandenberghe W, Nieuwboer A.
Neuroscience. 2012 Apr 5;207:298-306. Epub 2012 Jan 18.
Related citations
Conflict and freezing of gait in Parkinson's disease: support for a response control deficit.
Vandenbossche J, Deroost N, Soetens E, Zeischka P, Spildooren J, Vercruysse S, Nieuwboer A, Kerckhofs E.
Neuroscience. 2012 Mar 29;206:144-54. Epub 2012 Jan 12.
Development and characterisation of a novel rat model of Parkinson's disease induced by sequential intranigral administration of AAV-α-synuclein and the pesticide, rotenone.
Mulcahy P, O'Doherty A, Paucard A, O'Brien T, Kirik D, Dowd E.
Neuroscience. 2012 Feb 17;203:170-9. Epub 2011 Dec 13.
Effects of noradrenaline and serotonin depletions on the neuronal activity of globus pallidus and substantia nigra pars reticulata in experimental parkinsonism.
Delaville C, Navailles S, Benazzouz A.
Neuroscience. 2012 Jan 27;202:424-33. Epub 2011 Nov 25.
FLZ protects dopaminergic neuron through activating protein kinase B/mammalian target of rapamycin pathway and inhibiting RTP801 expression in Parkinson's disease models.
Bao XQ, Kong XC, Qian C, Zhang D.
Neuroscience. 2012 Jan 27;202:396-404. Epub 2011 Nov 25.
Neurotoxin-based models of Parkinson's disease.
Bové J, Perier C.
Neuroscience. 2012 Jun 1;211:51-76. Epub 2011 Nov 10.
Dynamic modeling of α-synuclein aggregation in dopaminergic neuronal system indicates points of neuroprotective intervention: experimental validation with implications for Parkinson's therapy.
Sultana Z, Paleologou KE, Al-Mansoori KM, Ardah MT, Singh N, Usmani S, Jiao H, Martin FL, Bharath MM, Vali S, El-Agnaf OM.
Neuroscience. 2011 Dec 29;199:303-17. Epub 2011 Oct 20.
Expression of frontotemporal dementia with parkinsonism associated to chromosome 17 tau induces specific degeneration of the ventral dentate gyrus and depressive-like behavior in mice.
Llorens-Martin M, Hernandez F, Avila J.
Neuroscience. 2011 Nov 24;196:215-27. Epub 2011 Aug 27.
Chronic progesterone treatment of male rats with unilateral 6-hydroxydopamine lesion of the dorsal striatum exasperates parkinsonian symptoms.
Chao OY, Huston JP, von Bothmer A, Pum ME.
Neuroscience. 2011 Nov 24;196:228-36. Epub 2011 Aug 25.
The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease.
Surmeier DJ, Guzman JN, Sanchez-Padilla J, Schumacker PT.
Neuroscience. 2011 Dec 15;198:221-31. Epub 2011 Aug 25. Review.
Glial cell-line derived neurotrophic factor is essential for electroconvulsive shock-induced neuroprotection in an animal model of Parkinson's disease.
Anastasía A, Wojnacki J, de Erausquin GA, Mascó DH.
Neuroscience. 2011 Nov 10;195:100-11. Epub 2011 Aug 16.
Modulation of the activity of globus pallidus by dopamine D1-like receptors in parkinsonian rats.
Chen L, Qi R, Chen XY, Xue Y, Xu R, Wei HJ.
Neuroscience. 2011 Oct 27;194:181-8. Epub 2011 Aug 6.
Protective effects of valproic acid on the nigrostriatal dopamine system in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
Kidd SK, Schneider JS.
Neuroscience. 2011 Oct 27;194:189-94. Epub 2011 Aug 6.
Aberrant striatal synaptic plasticity in monogenic parkinsonisms.
Madeo G, Martella G, Schirinzi T, Ponterio G, Shen J, Bonsi P, Pisani A.
Neuroscience. 2012 Jun 1;211:126-35. Epub 2011 Aug 2.
Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson's disease model.
Carta AR, Frau L, Pisanu A, Wardas J, Spiga S, Carboni E.
Neuroscience. 2011 Oct 27;194:250-61. Epub 2011 Jul 27.
Functional reorganization of the presynaptic dopaminergic terminal in parkinsonism.
Bergstrom BP, Sanberg SG, Andersson M, Mithyantha J, Carroll FI, Garris PA.
Neuroscience. 2011 Oct 13;193:310-22. Epub 2011 Jul 20.
Proprioceptive deficits in Parkinson's disease patients with freezing of gait.
Tan T, Almeida QJ, Rahimi F.
Neuroscience. 2011 Sep 29;192:746-52. Epub 2011 Jul 1.
Glyceraldehyde-3-phosphate dehydrogenase: activity inhibition and protein overexpression in rotenone models for Parkinson's disease.
Huang J, Xiong N, Chen C, Xiong J, Jia M, Zhang Z, Cao X, Liang Z, Sun S, Lin Z, Wang T.
Neuroscience. 2011 Sep 29;192:598-608. Epub 2011 Jun 23.
Intrinsic dynamics and synaptic inputs control the activity patterns of subthalamic nucleus neurons in health and in Parkinson's disease.
Wilson CJ, Bevan MD.
Neuroscience. 2011 Dec 15;198:54-68. Epub 2011 Jun 22.
Walking in circles: navigation deficits from Parkinson's disease but not from cerebellar ataxia.
Paquette C, Franzén E, Jones GM, Horak FB.
Neuroscience. 2011 Sep 8;190:177-83. Epub 2011 Jun 14.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on